Qiagen (QGEN) revenue

Revenue · fiscal 2025
$2.09B

Qiagen (QGEN) reported revenue of $2.09B in fiscal 2025 (the year ended December 31, 2025). That is 5.7% higher than the $1.98B of fiscal 2024. Figures as of 19 Nov 2026, 11:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$2.09B
Change on fiscal 2024
+5.7%
Growth, 5 years
+2.2% a year
Growth, 10 years
+5.0% a year
Highest on record
$2.25Bfiscal 2021
Lowest on record
$892.98Mfiscal 2008
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Qiagen revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 2.2% a year; over ten years the rate was 5.0% a year. Across the 18 fiscal years on record (2008–2025), the highest was $2.25B in fiscal 2021 and the lowest $892.98M in fiscal 2008.

History · 18 fiscal years

Revenue by fiscal year

Qiagen revenue, year by year

Qiagen (QGEN) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$2.09B 5.7% up
2024$1.98B 0.7% up
2023$1.97B 8.2% down
2022$2.14B 4.9% down
2021$2.25B 20.4% up
2020$1.87B 22.5% up
2019$1.53B 1.6% up
2018$1.50B 5.9% up
2017$1.42B 5.9% up
2016$1.34B 4.5% up
2015$1.28B 4.7% down
2014$1.34B 3.3% up
2013$1.30B 3.8% up
2012$1.25B 7.2% up
2011$1.17B 7.6% up
2010$1.09B 7.7% up
2009$1.01B 13.1% up
2008$892.98M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Qiagen and comparable companies
CompanyRevenueFiscal year
Bio-Rad Laboratories BIO$2.58B2025
Molina Healthcare MOH$45.43B2025
Spyre Therapeutics SYRE$886.00K2023
Qiagen QGEN$2.09B2025
Insulet PODD$2.71B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on QGEN

Qiagen, figure by figure

Qiagen (QGEN) overview: price, valuation and scorecardAll health care companies by market value

Qiagen revenue: questions and answers

What is Qiagen's revenue?

Qiagen (QGEN) reported revenue of $2.09B in fiscal 2025 (the year ended December 31, 2025). That is 5.7% higher than the $1.98B of fiscal 2024.

What is the growth rate of Qiagen's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 2.2% a year; over ten years the rate was 5.0% a year.

What are the highest and lowest revenue figures on record for Qiagen?

Across the 18 fiscal years on record (2008–2025), the highest was $2.25B in fiscal 2021 and the lowest $892.98M in fiscal 2008.

How is Qiagen's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Qiagen it is on record here for 18 fiscal years, 2008 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Qiagen (QGEN) revenue”, data as of 19 November 2026. https://funkfolio.com/stock/QGEN/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.